Innovative approach could improve cancer immunotherapy
A clinical trial is currently investigating the potential of CD40L-enhanced…
A clinical trial is currently investigating the potential of CD40L-enhanced tumour-infiltrating lymphocyte (TIL) cancer therapy in non-small cell lung cancer.